Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial

Antonio González-Martín, Christophe Desauw, Florian Heitz, Claire Cropet, Piera Gargiulo, Regina Berger, Hiroyuki Ochi, Ignace Vergote, Nicoletta Colombo, Mansoor Raza Mirza, Youssef Tazi, Ulrich Canzler, Claudio Zamagni, Eva M. Guerra-Alia, Charles B. Levaché, Frederik Marmé, Fernando Bazan, Nikolaus De Gregorio, Nadine Dohollou, Peter A. FaschingGiovanni Scambia, María J. Rubio-Pérez, Tsveta Milenkova, Cristina Costan, Patricia Pautier, Isabelle Ray-Coquard

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Fingerprint

Entra nei temi di ricerca di 'Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial'. Insieme formano una fingerprint unica.

Medicine and Dentistry